BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 14730031)

  • 21. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases].
    Li AJ; Zhou WP; Wu MC
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):321-3. PubMed ID: 16635391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation.
    Buetow PC; Pantongrag-Brown L; Buck JL; Ros PR; Goodman ZD
    Radiographics; 1996 Mar; 16(2):369-88. PubMed ID: 8966294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR imaging of focal nodular hyperplasia of the liver: value of contrast-enhanced dynamic study.
    Irie H; Honda H; Kaneko K; Kuroiwa T; Fukuya T; Yoshimitsu K; Ono M; Kawanami T; Yoshida M; Maeda T; Masuda K
    Radiat Med; 1997; 15(1):29-35. PubMed ID: 9134582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children.
    Valentino PL; Ling SC; Ng VL; John P; Bonasoni P; Castro DA; Taylor G; Chavhan GB; Kamath BM
    Liver Int; 2014 Feb; 34(2):227-34. PubMed ID: 23829376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.
    McInnes MD; Hibbert RM; InĂ¡cio JR; Schieda N
    Radiology; 2015 Nov; 277(2):413-23. PubMed ID: 26020440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and algorithm for focal nodular hyperplasia of the liver in children.
    Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Onodera Y; Itoh T; Todo S
    Eur J Pediatr Surg; 2006 Aug; 16(4):235-40. PubMed ID: 16981086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation.
    Krinsky GA; Israel G
    AJR Am J Roentgenol; 2003 Apr; 180(4):1023-7. PubMed ID: 12646448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign liver tumors].
    Cherqui D
    J Chir (Paris); 2001 Feb; 138(1):19-26. PubMed ID: 11240457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.
    Alberti N; Frulio N; Bioulac-Sage P; Laumonier H; Balabaud C; Perez JT; Teixeira FR; Harbonnier N; Trillaud H
    Diagn Interv Imaging; 2014 Jan; 95(1):77-83. PubMed ID: 24139183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
    van den Esschert JW; van Gulik TM; Phoa SS
    Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiological features of focal nodular hyperplasia of the liver in children.
    Cheon JE; Kim WS; Kim IO; Jang JJ; Seo JK; Yeon KM
    Pediatr Radiol; 1998 Nov; 28(11):878-83. PubMed ID: 9799323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT and MR imaging of benign hepatic and biliary tumors.
    Horton KM; Bluemke DA; Hruban RH; Soyer P; Fishman EK
    Radiographics; 1999; 19(2):431-51. PubMed ID: 10194789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.